It was Stupid to Underestimate Jaguar Health (NASDAQ: JAGX)

Jeff Siegel

Written By Jeff Siegel

Posted January 5, 2021

I knew Jaguar Health (NASDAQ: JAGX) was a bargain when it was trading below $1.00.

Not just because the stock is worth at least $1.00, but because in order to maintain compliance with the NASDAQ, the stock had to trade back up over $1.00, and stay there for at least 15 days.

So I recommended it to my readers as a no-brainer trade after the company locked in a deal that would help put the stock get back over a buck.  And when the stock crossed $1.00, I sold it, feeling pretty good about locking in a quick 40% gain in less than 2 weeks.

Then the stock kept roaring higher, and higher.

This morning, the stock hit $2.99 before selling off.

In my attempt to avoid risking some quick money, I ended up losing out on a 200%+ gain.

My reaction …


I suppose I shouldn’t cry over missed gains, but damn that one hurt. 

I should’ve known better, too, as Jaguar Health is actually a solid company,  It would’ve made more sense to go long on this one.

Oh well.  I’ll just take my 40% gain and my humility and move on. 🙂


Angel Publishing Investor Club Discord - Chat Now

Jeff Siegel Premium


Hydrogen Fuel Cells: The Downfall of Tesla?

Lithium has been the front-runner in the battery technology market for years, but that is all coming to an end. Elon Musk is against them, but Jeff Bezos is investing heavily in them. Hydrogen Fuel Cells will turn the battery market upside down and we've discovered a tiny company that is going to make it happen...

Sign up to receive your free report. After signing up, you'll begin receiving the Energy and Capital e-letter daily.